Chicago, Illinois–(Newsfile Corp. – January 21, 2026) – Mag Mile Capital (OTCQB: MMCP) is pleased to announce the successful arrangement of $47.61 million in total financings across five recent commercial real estate transactions, including a multi-tenant retail strip center in Chicagoland, a single-tenant special purpose property in Greater New York area, a marina asset in […]
Distinctive Assets, the LA-based entertainment marketing company credited with catapulting the promotional craze of celebrity swag into a pop culture phenomenon, will serve as the Recording Academy®’s exclusive talent gifting partner for an astounding 26th year. Distinctive Assets will once again produce the one-and-only Grammy® Gift Lounge as well as the show’s legendary Presenter &
Clinician-Led Organization Enters 2026 with Eight Hospital Partners Symmetry Anesthesia, a physician-led anesthesia organization launched in mid-2025, has rapidly expanded its footprint, onboarding five hospitals and hiring more than 250 clinicians in its first five months. The group now partners with eight hospitals as it enters 2026. “Anesthesia was broken–profits were prioritized over practice,” said
The Current Generation of Young Adults Balanced Frugality With Conviction to End 2025. Lone Star Botanicals' Robust Line of Clean Supplements Can Equip Them to Do Both in 2026. Lone Star Botanicals is a brand committed to robust quality standards and responsible sourcing. These corporate convictions align closely with new reports that find younger consumer
Market News Updates News Commentary Next-generation robotics platforms are expanding addressable markets and unlocking long-term recurring revenue potential The humanoid robot industry is influenced by evolving needs in personal assistance, healthcare, and industrial automation. Trends such as AI-driven human-robot interaction, advanced mobility and dexterity, and integration with IoT and cloud platforms directly enhance functionality and
(NasdaqGM:ACTU), -Initiation of phase 1 portion of the trial planned in 2H 2026 -Phase 2 portion of the trial will initiate development of the elraglusib tablet in specific indications, including refractory melanoma and additional target solid tumor and hematologic cancers -Program builds on early clinical evidence of monotherapy activity observed in immune checkpoint inhibitor (CPI)-refractory
(NYSE MKT:AGIG), Highlights vertically integrated waste-to-value platform and 2026 operational milestones HOUSTON, TX, Jan. 21, 2026 (GLOBE NEWSWIRE) — Abundia Global Impact Group, Inc. (NYSE American: AGIG) (“Abundia” or the “Company”), a low-carbon energy solutions company focused on converting biomass and plastics waste into high-value low-carbon fuels, announces it has published an updated investor presentation,
Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers GlobeNewswire January 21, 2026 -Initiation of phase 1 portion of the trial planned in 2H 2026 -Phase 2 portion of the trial will initiate development of the elraglusib tablet in specific indications, including refractory melanoma
Abundia Global Impact Group Publishes Updated Investor Presentation GlobeNewswire January 21, 2026 Highlights vertically integrated waste-to-value platform and 2026 operational milestones HOUSTON, TX, Jan. 21, 2026 (GLOBE NEWSWIRE) — Abundia Global Impact Group, Inc. (NYSE American: AGIG) (“Abundia” or the “Company”), a low-carbon energy solutions company focused on converting biomass and plastics waste into high-value
Better Blend, the fast-growing smoothie brand known for its low-sugar, high-protein smoothies, announced its expansion into Florida with three franchise-owned locations planned for the Tampa market, and two food trucks designed for community events, fitness activations, and local pop-ups. The Florida expansion marks Better Blend’s first entry into the state and reflects growing demand across